Neuroendocrine Differentiation, Microsatellite Instability, and Tumor-infiltrating Lymphocytes in Advanced Colorectal Cancer With BRAF Mutation-Reference-Cited by-同舟云学术

Neuroendocrine Differentiation, Microsatellite Instability, and Tumor-infiltrating Lymphocytes in Advanced Colorectal Cancer With BRAF Mutation

Published:2019-06 Issue:2 Volume:18 Page:e251-e260
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Digiacomo Nunzio^ORCID,Bolzacchini Elena,Veronesi Giovanni^ORCID,Cerutti Roberta,Sahnane Nora^ORCID,Pinotti Graziella,Bregni Marco,Artale Salvatore,Verusio Claudio^ORCID,Crivelli Filippo,Capella Carlo,Sessa Fausto^ORCID,Furlan Daniela^ORCID

Funder

Epigenomics Flagship Project

University of Insubria

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference42 articles.

1. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status;Rajagopalan;Nature,2002

2. BRAF mutation in sporadic colorectal cancer and Lynch syndrome;Thiel;Virchows Arch,2013

3. The BRAF oncoprotein functions through the transcriptional repressor MAFG to mediate the CpG Island Methylator phenotype;Fang;Mol Cell,2014

4. Lynch syndrome-associated colorectal cancer;Sinicrope;N Engl J Med,2018

5. Deficient mismatch repair system in patients with sporadic advanced colorectal cancer;Koopman;Br J Cancer,2009

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune check point inhibitors in BRAF mutated metastatic colorectal cancer: A review;International Journal of Gastrointestinal Intervention;2024-07-31

2. Molecular features of gastroenteropancreatic neuroendocrine carcinoma: A comparative analysis with lung neuroendocrine carcinoma and digestive adenocarcinomas;Chinese Journal of Cancer Research;2024

3. Pathological Evaluation and Classification of Digestive Neuroendocrine Neoplasms;Neuroendocrine Tumours;2024

4. Immune checkpoint blockade therapy for BRAF mutant metastatic colorectal cancer: the efficacy, new strategies, and potential biomarkers;Discover Oncology;2023-06-11

5. Tumor Antigenicity and a Pre-Existing Adaptive Immune Response in Advanced BRAF Mutant Colorectal Cancers;Cancers;2022-08-16